Parkman Healthcare Partners
Latest statistics and disclosures from Parkman Healthcare Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are MBX, LLY, CVS, DXCM, PTCT, and represent 20.29% of Parkman Healthcare Partners's stock portfolio.
- Added to shares of these 10 stocks: INBX (+$24M), UNH (+$23M), VRDN (+$15M), INDV (+$15M), AVTX (+$14M), GPCR (+$14M), DRUG (+$12M), ANRO (+$11M), ORKA (+$11M), EWTX (+$10M).
- Started 18 new stock positions in SPRY, ORKA, CLYM, VTRS, SI, Hemab Therapeutics Holdings, INBX, TARS, INDV, RMD. AXSM, AVAH, AVTX, Grail, UNH, ANRO, CYRX, EIKN.
- Reduced shares in these 10 stocks: Kalvista Pharmaceuticals (-$37M), SYK (-$27M), QGEN (-$20M), , LIVN (-$16M), ILMN (-$14M), , , KNSA (-$13M), BSX (-$12M).
- Sold out of its positions in ADMA, ABBV, ARAY, APGE, AXGN, BFLY, CVRX, CAI, CMPS, COO.
- Parkman Healthcare Partners was a net seller of stock by $-91M.
- Parkman Healthcare Partners has $977M in assets under management (AUM), dropping by 0.74%.
- Central Index Key (CIK): 0001777015
Tip: Access up to 7 years of quarterly data
Positions held by Parkman Healthcare Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 77 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Mbx Biosciences (MBX) | 4.5 | $44M | 800k | 55.20 |
|
|
| Eli Lilly & Co. (LLY) | 4.3 | $42M | 35k | 1199.43 |
|
|
| CVS Caremark Corporation (CVS) | 4.1 | $41M | 392k | 103.45 |
|
|
| Dex (DXCM) | 3.7 | $36M | -22% | 535k | 67.35 |
|
| Ptc Therapeutics I (PTCT) | 3.6 | $36M | 436k | 81.57 |
|
|
| Arcus Biosciences Incorporated (RCUS) | 2.9 | $28M | -23% | 919k | 30.83 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 2.7 | $26M | +109% | 486k | 53.67 |
|
| Miragen Therapeutics (VRDN) | 2.6 | $25M | +146% | 1.4M | 18.37 |
|
| Agios Pharmaceuticals (AGIO) | 2.5 | $25M | +65% | 669k | 37.11 |
|
| Inhibrx Biosciences (INBX) | 2.5 | $24M | NEW | 257k | 94.75 |
|
| Xenon Pharmaceuticals (XENE) | 2.5 | $24M | -20% | 397k | 60.36 |
|
| Edgewise Therapeutics (EWTX) | 2.4 | $23M | +78% | 577k | 40.63 |
|
| UnitedHealth (UNH) | 2.4 | $23M | NEW | 56k | 415.63 |
|
| Stryker Corporation (SYK) | 2.2 | $21M | -56% | 68k | 314.84 |
|
| Iqvia Holdings (IQV) | 2.1 | $20M | +22% | 106k | 193.22 |
|
| Zimmer Holdings (ZBH) | 2.0 | $20M | -13% | 233k | 86.09 |
|
| Insulet Corporation (PODD) | 2.0 | $20M | -16% | 131k | 152.25 |
|
| Assembly Biosciences Com New (ASMB) | 2.0 | $20M | +75% | 721k | 27.48 |
|
| Syndax Pharmaceuticals (SNDX) | 2.0 | $19M | -2% | 877k | 21.86 |
|
| Eyepoint Com New (EYPT) | 1.9 | $18M | -4% | 1.3M | 14.30 |
|
| Tenet Healthcare Corp Com New (THC) | 1.9 | $18M | +94% | 97k | 187.08 |
|
| Livanova SHS (LIVN) | 1.8 | $17M | -47% | 211k | 82.23 |
|
| Biosante Pharmaceuticals (ANIP) | 1.7 | $17M | -27% | 203k | 82.78 |
|
| BioCryst Pharmaceuticals (BCRX) | 1.7 | $16M | -4% | 1.6M | 10.00 |
|
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $15M | +88% | 51k | 301.03 |
|
| Indivior Pharmaceuticals (INDV) | 1.5 | $15M | NEW | 364k | 41.03 |
|
| Envista Hldgs Corp (NVST) | 1.5 | $15M | -22% | 554k | 26.35 |
|
| Bright Minds Biosciences Com New (DRUG) | 1.5 | $14M | +411% | 205k | 70.20 |
|
| Xeris Pharmaceuticals (XERS) | 1.5 | $14M | +5% | 1.8M | 7.92 |
|
| Avalo Therapeutics Com New (AVTX) | 1.4 | $14M | NEW | 766k | 18.48 |
|
| 4d Molecular Therapeutics In (FDMT) | 1.3 | $13M | +81% | 948k | 13.30 |
|
| Immunome (IMNM) | 1.3 | $13M | +47% | 594k | 21.19 |
|
| Stoke Therapeutics (STOK) | 1.2 | $12M | +5% | 355k | 32.72 |
|
| Waters Corporation (WAT) | 1.2 | $11M | +14% | 30k | 375.04 |
|
| Alto Neuroscience Com Shs (ANRO) | 1.2 | $11M | NEW | 429k | 26.39 |
|
| Oruka Therapeutics (ORKA) | 1.1 | $11M | NEW | 113k | 95.17 |
|
| Adaptive Biotechnologies Cor (ADPT) | 1.1 | $10M | -11% | 487k | 21.45 |
|
| Absci Corp (ABSI) | 1.1 | $10M | -52% | 894k | 11.59 |
|
| Mineralys Therapeutics (MLYS) | 1.1 | $10M | 380k | 26.98 |
|
|
| Cogent Biosciences (COGT) | 1.0 | $9.8M | +153% | 253k | 38.70 |
|
| Uniqure Nv SHS (QURE) | 1.0 | $9.6M | 208k | 46.06 |
|
|
| Tarsus Pharmaceuticals (TARS) | 1.0 | $9.4M | NEW | 150k | 62.94 |
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 1.0 | $9.4M | +79% | 541k | 17.31 |
|
| Irhythm Technologies (IRTC) | 0.8 | $8.0M | +67% | 67k | 118.95 |
|
| Cryoport Com Par $0.001 (CYRX) | 0.8 | $8.0M | NEW | 508k | 15.70 |
|
| Boston Scientific Corporation (BSX) | 0.8 | $7.7M | -59% | 181k | 42.68 |
|
| Eliem Therapeutics (CLYM) | 0.8 | $7.3M | NEW | 564k | 13.04 |
|
| Amylyx Pharmaceuticals (AMLX) | 0.7 | $7.2M | -35% | 399k | 17.96 |
|
| Upstream Bio (UPB) | 0.7 | $6.5M | +18% | 935k | 6.92 |
|
| ResMed (RMD) | 0.7 | $6.4M | NEW | 33k | 194.88 |
|
| Urogen Pharma (URGN) | 0.7 | $6.4M | -36% | 174k | 36.80 |
|
| Align Technology (ALGN) | 0.6 | $6.2M | +74% | 37k | 168.66 |
|
| Carlsmed (CARL) | 0.6 | $6.2M | +14% | 597k | 10.38 |
|
| Aveanna Healthcare Hldgs (AVAH) | 0.6 | $6.1M | NEW | 715k | 8.57 |
|
| Caredx (CDNA) | 0.6 | $5.8M | -30% | 202k | 28.50 |
|
| Si-bone (SIBN) | 0.5 | $5.4M | -12% | 329k | 16.32 |
|
| Vir Biotechnology (VIR) | 0.5 | $4.8M | -4% | 475k | 10.19 |
|
| Erasca (ERAS) | 0.5 | $4.7M | -36% | 259k | 18.32 |
|
| Shoulder Innovations Common Stock (SI) | 0.5 | $4.6M | NEW | 226k | 20.28 |
|
| Waystar Holding Corp (WAY) | 0.4 | $4.2M | -53% | 204k | 20.53 |
|
| Alphatec Hldgs Com New (ATEC) | 0.4 | $3.9M | -45% | 450k | 8.65 |
|
| Annexon (ANNX) | 0.4 | $3.7M | -4% | 641k | 5.71 |
|
| Castle Biosciences (CSTL) | 0.4 | $3.5M | +14% | 145k | 23.85 |
|
| Minimed Group (MMED) | 0.3 | $3.4M | -28% | 226k | 14.95 |
|
| Eikon Therapeutics (EIKN) | 0.3 | $3.3M | NEW | 256k | 13.05 |
|
| Viatris (VTRS) | 0.3 | $3.2M | NEW | 200k | 15.88 |
|
| Grail Put Put Option | 0.3 | $3.1M | NEW | 46k | 68.27 |
|
| CryoLife (AORT) | 0.3 | $3.1M | -44% | 139k | 22.47 |
|
| Axsome Therapeutics (AXSM) | 0.3 | $2.4M | NEW | 10k | 244.77 |
|
| Optimizerx Corp Com New (OPRX) | 0.2 | $2.0M | -51% | 350k | 5.72 |
|
| Inspiremd (NSPR) | 0.2 | $1.7M | 2.4M | 0.70 |
|
|
| Hemab Therapeutics Hldgs Com Shs | 0.2 | $1.7M | NEW | 45k | 36.73 |
|
| Pulmonx Corp (LUNG) | 0.1 | $841k | -14% | 647k | 1.30 |
|
| Silverback Therapeutics (SPRY) | 0.1 | $823k | NEW | 103k | 8.01 |
|
| Edap Tms S A Sponsored Adr (FOCL) | 0.1 | $802k | 155k | 5.18 |
|
|
| Ovid Therapeutics (OVID) | 0.1 | $533k | -4% | 198k | 2.69 |
|
| Entera Bio SHS (ENTX) | 0.0 | $486k | -4% | 275k | 1.77 |
|
Past Filings by Parkman Healthcare Partners
SEC 13F filings are viewable for Parkman Healthcare Partners going back to 2019
- Parkman Healthcare Partners 2026 Q2 filed Aug. 14, 2026
- Parkman Healthcare Partners 2026 Q1 filed May 15, 2026
- Parkman Healthcare Partners 2025 Q4 filed Feb. 17, 2026
- Parkman Healthcare Partners 2025 Q3 filed Nov. 14, 2025
- Parkman Healthcare Partners 2025 Q2 filed Aug. 14, 2025
- Parkman Healthcare Partners 2025 Q1 filed May 15, 2025
- Parkman Healthcare Partners 2024 Q4 filed Feb. 14, 2025
- Parkman Healthcare Partners 2024 Q3 filed Nov. 14, 2024
- Parkman Healthcare Partners 2024 Q2 filed Aug. 14, 2024
- Parkman Healthcare Partners 2024 Q1 filed May 15, 2024
- Parkman Healthcare Partners 2023 Q3 filed Nov. 14, 2023
- Parkman Healthcare Partners 2023 Q2 filed Aug. 11, 2023
- Parkman Healthcare Partners 2023 Q1 filed May 12, 2023
- Parkman Healthcare Partners 2022 Q4 filed Feb. 13, 2023
- Parkman Healthcare Partners 2022 Q3 filed Nov. 14, 2022
- Parkman Healthcare Partners 2022 Q2 filed Aug. 12, 2022